Advertisement

Purinergic Signalling

, Volume 14, Issue 1, pp 91–96 | Cite as

UDP-induced relaxation is enhanced in aorta from female obese Otsuka Long–Evans Tokushima Fatty rats

  • Shota Kobayashi
  • Takayuki Matsumoto
  • Makoto Ando
  • Maika Iguchi
  • Shun Watanabe
  • Kumiko Taguchi
  • Tsuneo KobayashiEmail author
Brief Communication

Abstract

Uridine 5′-diphosphate (UDP) plays an important role in controlling vascular tone; however, UDP-mediated response in metabolic syndromes, including obesity and type 2 diabetes in females, remains unclear. In this study, we investigated UDP-mediated response in the aorta of female obese Otsuka Long–Evans Tokushima Fatty (OLETF) rats and control Long–Evans Tokushima Otsuka (LETO) rats. In OLETF rat aortas precontracted by phenylephrine (PE) (vs. LETO), (1) UDP-induced relaxation was increased, whereas acetylcholine (ACh)-induced relaxation was decreased; (2) no UDP- or ACh-induced relaxations were observed in endothelial denudation, whereas UDP-induced small contraction was observed; and (3) NG-nitro-L-arginine [L-NNA, a nitric oxide (NO) synthase inhibitor] eliminated UDP-induced relaxation and small contraction, whereas caused contrasting responses by ACh, including slight relaxations (LETO) and contractions (OLETF). Indomethacin, a cyclooxygenase inhibitor, eliminated the difference in UDP- and ACh-induced relaxations between the groups by increased UDP-induced relaxation in the LETO group and increased ACh-induced relaxation in the OLETF group. MRS2578, a P2Y6 receptor antagonist, eliminated the difference in UDP-induced relaxations between the groups by decreasing UDP-induced relaxation in the OLETF group. MRS2578 had no effect on UDP-induced contraction in endothelium-denuded aortas. Therefore, these findings demonstrate opposite trends of relaxations by UDP and ACh in OLETF and LETO rat aortas. These differences may be attributed to the imbalance between NO and vasoconstrictor prostanoids upon stimulations. Increased UDP-induced relaxation in OLETF rat aorta may be caused by the activation of endothelial MRS2578-sensitive P2Y6 receptor.

Keywords

Obese Female P2Y6 Relaxation UDP 

Abbreviations

ACh

Acetylcholine

COX

Cyclooxygenase

EDCF

Endothelium-derived contracting factor

EDRF

Endothelium-derived relaxing factor

KHS

Krebs–Henseleit Solution

LETO

Long-Evans Tokushima Otsuka

L-NNA

NG-nitro-L-arginine

NO

Nitric oxide

NOS

Nitric oxide synthase

OLETF

Otsuka Long-Evans Tokushima Fatty

PE

Phenylephrine

SNP

Sodium nitroprusside

UDP

Uridine 5′-diphosphate

Notes

Acknowledgements

We thank T. Kamioka, S. Oshima, Y. Ohta, S. Ohashi, A. Ozeki, S. Takeno, M. Tani, and M. Tamura for technical assistance. This study was supported in part by JSPS KAKENHI Grant Numbers JP17K08318 and JP15K07975 and by the Suzuken Memorial Foundation (Japan). The authors would like to thank Enago (www.enago.jp) for the English language review.

Compliance with ethical standards

Conflicts of interest

Shota Kobayashi declares that he has no conflict of interest.

Takayuki Matsumoto declares that he has no conflict of interest.

Makoto Ando declares that he has no conflict of interest.

Maika Iguchi declares that he/she has no conflict of interest.

Shun Watanabe declares that he has no conflict of interest.

Kumiko Taguchi declares that she has no conflict of interest.

Tsuneo Kobayashi declares that he has no conflict of interest.

Ethical approval

This study was approved by the Hoshi University Animal Care and Use Committee, and all studies were conducted in accordance with the Guide for the Care and Use of Laboratory Animals, published by the US National Institutes of Health, and the Guide for the Care and Use of Laboratory Animals adopted by the Committee on the Care and Use of Laboratory Animals of Hoshi University (accredited by the Ministry of Education, Culture, Sports, Science, and Technology, Japan).

Supplementary material

11302_2017_9595_MOESM1_ESM.doc (1.3 mb)
ESM 1 (DOC 1.25 mb)

References

  1. 1.
    Burnstock G, Ralevic V (2014) Purinergic signaling and blood vessels in health and disease. Pharmacol Rev 66:102–192.  https://doi.org/10.1124/pr.113.008029 CrossRefPubMedGoogle Scholar
  2. 2.
    Erlinge D, Burnstock G (2008) P2 receptors in cardiovascular regulation and disease. Prinergic Signal 4:1–20.  https://doi.org/10.1007/s11302-007-9078-7 CrossRefGoogle Scholar
  3. 3.
    Burnstock G (2017) Purinergic signaling in the cardiovascular system. Circ Res 120:207–228.  https://doi.org/10.1161/CIRCRESAHA.116.309726 CrossRefPubMedGoogle Scholar
  4. 4.
    Zhang Z, Wang Z, Ren H, Yue M, Huang K, Gu H, Liu M, Du B, Qian M (2011) P2Y(6) agonist uridine 5′-diphosphate promotes host defense against bacterial infection via monocyte chemoattractant protein-1-mediated monocyte/macrophage recruitment. J Immunol 186:5376–5387.  https://doi.org/10.4049/jimmunol.1002946 CrossRefPubMedGoogle Scholar
  5. 5.
    Stachon P, Peikert A, Michel NA, Hergeth S, Marchini T, Wolf D, Dufner B, Hoppe N, Ayata CK, Grimm M, Cicko S, Schulte L, Reinohl J, von zur Muhlen C, Bode C, Idzko M, Zirlik A (2014) P2Y6 deficiency limits vascular inflammation and atherosclerosis in mice. Arterioscler Thromb Vasc Biol 34:2237–2245.  https://doi.org/10.1161/ATVBAHA.114.303585 CrossRefPubMedGoogle Scholar
  6. 6.
    Riegel AK, Faigle M, Zug S, Rosenberger P, Robaye B, Boeynaems JM, Idzko M, Eltzschig HK (2011) Selective induction of endothelial P2Y6 nucleotide receptor promotes vascular inflammation. Blood 117:2548–2555.  https://doi.org/10.1182/blood-2010-10-313957 CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Vial C, Evans RJ (2002) P2X1 receptor-deficient mice establish the native P2X receptor and a P2Y6-like receptor in arteries. Mol Pharmacol 62:1438–1445CrossRefPubMedGoogle Scholar
  8. 8.
    Malmsjo M, Hou M, Pendergast W, Erlinge D, Edvinsson L (2003) Potent P2Y6 receptor mediated contractions in human cerebral arteries. BMC Pharmacol 3:4CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Vonend O, Stegbauer J, Sojka J, Habbel S, Quack I, Robaye B, Boeynaems JM, Rumb LC (2005) Noradrenaline and extracellular nucleotide cotransmission involves activation of vasoconstrictive P2X(1,3)- and P2Y6-like receptors in mouse perfused kidney. Br J Pharmacol 145:66–74CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Kauffenstein G, Tamareille S, Prunier F, Roy C, Ayer A, Toutain B, Billaud M, Isakson BE, Grimaud L, Loufrani L, Rousseau P, Abraham P, Procaccio V, Monyer H, de Wit C, Boeynaems JM, Robaye B, Kwak BR, Henrion D (2016) Central role of P2Y6 UDP receptor in arteriolar myogenic tone. Arterioscler Thromb Vasc Biol 36:1598–1606.  https://doi.org/10.1161/ATVBAHA.116.307739 CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Haanes KA, Spray S, Syberg S, Jorgensen NR, Robaye B, Boeynaems JM, Edvinsson L (2016) New insight on pyrimidine signalling within the arterial vasculature—different roles for P2Y2 and P2Y6 receptors in large and small coronary arteries of the mouse. J Mol Coll Cardiol 93:1–11.  https://doi.org/10.1016/j.yjmcc.2016.01.025 CrossRefGoogle Scholar
  12. 12.
    Mitchell C, Syed NI, Tengah A, Gurney AM, Kennedy C (2012) Identification of contractile P2Y1, P2Y6, and P2Y12 receptors in rat intrapulmonary artery using selective ligands. J Pharmacol Exp Ther 343:755–762.  https://doi.org/10.1124/jpet.112.198051 CrossRefPubMedGoogle Scholar
  13. 13.
    Matsumoto T, Tostes RC, Webb RC (2012) Alterations in vasoconstrictor responses to the endothelium-derived contracting factor uridine adenosine tetraphosphate are region specific in DOCA-salt hypertensive rats. Pharmacol Res 65:81–90.  https://doi.org/10.1016/j.phrs.2011.09.005 CrossRefPubMedGoogle Scholar
  14. 14.
    Bar I, Guns PJ, Metallo J, Cammarata D, Wilkin F, Boeynams JM, Bult H, Robaye B (2008) Knockout mice reveal a role for P2Y6 receptor in macrophage, endothelial cells, and vascular smooth muscle cells. Mol Pharmacol 74:777–784.  https://doi.org/10.1124/mol.108.046904 CrossRefPubMedGoogle Scholar
  15. 15.
    Ballantyne CM, Hoogeveen RC, McNeill AM, Heiss G, Schmidt MI, Duncan BB, Pankow JS (2008) Metabolic syndrome risk for cardiovascular disease and diabetes in the ARIC study. Int J Obes 32:S21–S24.  https://doi.org/10.1038/ijo.2008.31 CrossRefGoogle Scholar
  16. 16.
    Kawano K, Hirashima T, Mori S, Saitoh Y, Kurosumi M, Natori T (1992) Spontaneous long-term hyperglycemic rat with diabetic complications. Otsuka Long-Evans Tokushima Fatty (OLETF) strain. Diabetes 41:1422–1428CrossRefPubMedGoogle Scholar
  17. 17.
    Kawano K, Hirashima T, Mori S, Natori T (1994) OLETF (Otsuka Long-Evans Tokushima Fatty) rat: a new NIDDM rat strain. Diabetes Res Clin Pract 24:S317–S320CrossRefPubMedGoogle Scholar
  18. 18.
    Moran TH, Bi S (2006) Hyperphagia and obesity of OLETF rats lacking CCK1 receptors: developmental aspects. Dev Psychobiol 48:360–367CrossRefPubMedGoogle Scholar
  19. 19.
    Schroeder M, Zagoory-Sharon O, Shbiro L, Marco A, Hyun J, Moran TH, Bi S, Weller A (2009) Development of obesity in the Otsuka Long-Evans Tokushima Fatty rat. Am J Physiol Regul Integr Comp Physiol 297:R1749–R1760.  https://doi.org/10.1152/ajpregu.00461.2009 CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Matsumoto T, Kakami M, Noguchi E, Kobayashi T, Kamata K (2007) Imbalance between endothelium-derived relaxing and contracting factors in mesenteric arteries from aged OLETF rats, a model of type 2 diabetes. Am J Physiol Heart Circ Physiol 293:H1480–H1490CrossRefPubMedGoogle Scholar
  21. 21.
    Matsumoto T, Noguchi E, Ishida K, Kobayashi T, Yamada N, Kamata K (2008) Metformin normalizes endothelial function by suppressing vasoconstrictor prostanoids in mesenteric arteries from OLETF rats, a model of type 2 diabetes. Am J Physiol Heart Circ Physiol 295:H1165–H1176.  https://doi.org/10.1152/ajpheart.00486.2008. CrossRefPubMedGoogle Scholar
  22. 22.
    Matsumoto T, Nakayama N, Ishida K, Kobayashi T, Kamata K (2009) Eicosapentaenoic acid improves imbalance between vasodilator and vasoconstrictor actions of endothelium-derived factors in mesenteric arteries from rat at chronic stage of type 2 diabetes. J Pharmacol Exp Ther 329:324–334.  https://doi.org/10.1124/jpet.108.148718 CrossRefPubMedGoogle Scholar
  23. 23.
    Matsumoto T, Watanabe S, Kawamura R, Taguchi K, Kobayashi T (2014) Epigallocatechin gallate attenuates ET-1-induced contraction in carotid artery from type 2 diabetic OLETF rat at chronic stage of disease. Life Sci 118:200–205.  https://doi.org/10.1016/j.lfs.2013.11.016 CrossRefPubMedGoogle Scholar
  24. 24.
    Matsumoto T, Watanabe S, Ando M, Yamada K, Iguchi M, Taguchi K, Kobayashi T (2016) Diabetes and age-related differences in vascular function of renal artery: possible involvement of endoplasmic reticulum stress. Rejuvenation Res 19:41–52.  https://doi.org/10.1089/rej.2015.1662 CrossRefPubMedGoogle Scholar
  25. 25.
    Kagota S, Yamaguchi Y, Nakamura K, Kunitomo M (2000) Altered endothelium-dependent responsiveness in the aortas and renal arteries of Otsuka Long-Evans Tokushima Fatty (OLETF) rats, a model of non-insulin-dependent diabetes mellitus. Gen Pharmacol 34:201–209CrossRefPubMedGoogle Scholar
  26. 26.
    Amon L, Hazut N, Tabachinik T, Weller A, Koren L (2016) Maternal testosterone and reproductive outcome in a rat model of obesity. Theriogenology 86:1042–1047.  https://doi.org/10.1016/j.theriogenology.2016.03.033 CrossRefGoogle Scholar
  27. 27.
    Schroeder M, Kronfeld-Schor N, Weller A (2013) Selective leptin insensitivity and alterations in female-reproductive patterns linked to hyperleptinemia during infancy. PLoS One 8:e59937.  https://doi.org/10.1371/journal.pone.0059937 CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Matsumoto T, Kobayashi S, Ando M, Watanabe S, Iguchi M, Taguchi K, Kobayashi T (2017) Impaired endothelium-derived hyperpolarization-type relaxation in superior mesenteric arteries isolated from female Otsuka Long-Evans Tokushima Fatty rats. Eur J Pharmacol 807:151–158.  https://doi.org/10.1016/j.ejphar.2017.03.062 CrossRefPubMedGoogle Scholar
  29. 29.
    McCarthy CG, Wenceslau CF, Goulopoulou S, Ogbi S, Matsumoto T, Webb RC (2016) Autoimmune therapeutic chloroquine lowers blood pressure and improves endothelial function in spontaneously hypertensive rats. Pharmacol Res 113:384–394.  https://doi.org/10.1016/j.phrs.2016.09.008. CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Alsaqati M, Chan SL, Ralevic V (2014) Investigation of the functional expression of purine and pyrimidine receptors in porcine isolated pancreatic arteries. Purinergic Sig 10:241–249.  https://doi.org/10.1007/s11302-013-9403-2 CrossRefGoogle Scholar
  31. 31.
    Matsumoto T, Goulopoulou S, Taguchi K, Tostes RC, Kobayashi T (2015) Constrictor prostanoids and uridine adenosine tetraphosphate: vascular mediators and therapeutic targets in hypertension and diabetes. Br J Pharmacol 172:3980–4001.  https://doi.org/10.1111/bph.13205 CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Vanhoutte PM, Shimokawa H, Feletou M, Tang EH (2017) Endothelial dysfunction and vascular disease—a 30th anniversary update. Acta Physiol 219:22–96.  https://doi.org/10.1111/apha.12646 CrossRefGoogle Scholar
  33. 33.
    Ishida K, Matsumoto T, Taguchi K, Kamata K, Kobayashi T (2011) Mechanisms underlying altered extracellular nucleotide-induced contractions in mesenteric arteries from rats in later-stage type 2 diabetes: effect of ANG II type 1 receptor antagonism. Am J Physiol Heart Circ Physiol 301:H1850–H1861.  https://doi.org/10.1152/ajpheart.00502.2011. CrossRefPubMedGoogle Scholar
  34. 34.
    Naderali EK, Brown MJ, Pickavance LC, Wilding JP, Doyle PJ, Williams G (2001) Dietary obesity in the rat induces endothelial dysfunction without causing insulin resistance: a possible role for triacylglycerols. Clin Sci 101:499–506CrossRefPubMedGoogle Scholar
  35. 35.
    Pieper GM, Siebeneich W, Moore-Hilton G, Roza AM (1997) Reversal by L-arginine of a dysfunctional arginine/nitric oxide pathway in the endothelium of the genetic diabetic BB rat. Diabetologia 40:910–915CrossRefPubMedGoogle Scholar
  36. 36.
    Ciana P, Fumagalli M, Trincavelli ML, Verderio C, Rosa P, Lecca D, Ferrario S, Parravicini C, Capra V, Gelosa P, Guerrini U, Belcredito S, Cimino M, Sironi L, Tremoli E, Rovati GE, Martini C, Abbracchio MP (2006) The orphan receptor GPR17 identified as a new dual uracil nucleotides/cysteinyl-leukotrienes receptor. EMBO J 25:4615–4627.  https://doi.org/10.1038/sj.emboj.7601341 CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Nishimura A, Sunggip C, Tozaki-Saitoh H, Shimauchi T, Numaga-Tomita T, Hirano K, Ide T, Boeynaems JM, Kurose H, Tsuda M, Robaye B, Inoue K, Nishida M (2016) Purinergic P2Y6 receptor heterodimerize with angiotensin AT1 receptors to promote angiotensin II-induced hypertension. Sci Signal 9:ra7.  https://doi.org/10.1126/scisignal.aac9187 CrossRefPubMedGoogle Scholar
  38. 38.
    Sunggip C, Nishimura A, Shimoda K, Numaga-Tomita T, Tsuda M, Nishida M (2017) Purinergic P2Y6 receptors: a new therapeutic target of age-dependent hypertension. Pharmacol Res 120:51–59.  https://doi.org/10.1016/j.phrs.2017.03.013 CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media B.V., part of Springer Nature 2017

Authors and Affiliations

  • Shota Kobayashi
    • 1
  • Takayuki Matsumoto
    • 1
  • Makoto Ando
    • 1
  • Maika Iguchi
    • 1
  • Shun Watanabe
    • 1
  • Kumiko Taguchi
    • 1
  • Tsuneo Kobayashi
    • 1
    Email author
  1. 1.Department of Physiology and Morphology, Institute of Medicinal ChemistryHoshi UniversityTokyoJapan

Personalised recommendations